Selectis Health, Inc. filed 3 current reports with the SEC under Item 5.02, which covers directors and officers leaving or being appointed, the latest on 2026-09-09. Between them they name 1 person, with 1 appointment and 1 departure. Each change below is quoted from the filing and linked to it.
Every change, newest first
Departing: Krystal Eckhart, Chief Executive Officer
Neither Mr. Schwartz nor Mr. Schapiro has been appointed to any committee of the Board as of the date of this Current Report on Form 8-K.Other than as described above and in the Merger Agreement, neither Mr. Schwartz nor Mr. Schapiro has any interest, direct or indirect, in any transaction, or any currently proposed transaction, required to be disclosed pursuant to Item 404(a)of Regulation S-K. On September 1, 2026, Krystal Eckhart resigned as Interim Chief Executive Officer of the Company, effective immediately.
Appointed: Krystal Eckhart
On May 15, 2026, the Board of Directors of the Company appointed Krystal Eckhart to serve as the Company's Interim CEO and CFO.
Reported
DEPARTURE OF EXECUTIVE OFFICER AND DIRECTOR; APPOINTMENT OF EXECUTIVE OFFICER On March 30, 2026, David Furstenberg submitted his letter of resignation as a member of the Board of Directors and Audit Committee of Selectis Health, Inc., a Utah corporation (the "Company"), effective immediately.
Find people with the same kind of experience as the Chief Executive Officer at Selectis Health, Inc., with the record behind each one.
Find candidates like Chief Executive Officer at Selectis Health, Inc.New leaders review vendors and budgets in their first months. Get an alert the next time Selectis Health, Inc. is in the news or changes leadership.
Get an alert when Selectis Health, Inc. changes leadershipTools for this story
Each opens in a new tab, filled in for Selectis Health, Inc.. With no account yet, you sign up free and land on the result.
Where this comes from
A public company must file a current report on Form 8-K with the SEC within four business days when a director leaves or is elected, or when its chief executive, chief financial, chief accounting or chief operating officer, or another named executive, departs or is appointed. That disclosure goes under Item 5.02 of the report.
Every change on this page is taken from one of those filings and quoted in the company's own words, with a link to the filing, so it can be checked at the source. Where a filing names the person, the role and the date a change takes effect, they are shown beside the quote. Where it does not, the quote stands on its own. A filing states what changed; it rarely states why, and neither does this page.